<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN" "JATS-archivearticle1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPSIM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Pakistan Society of Internal Medicine</journal-title>
        <abbrev-title>J Pak Soc Intern Med</abbrev-title>
      </journal-title-group>
      <issn publication-format="print">2709-8729</issn>
      <issn publication-format="electronic">2710-0804</issn>
      <publisher>
        <publisher-name>Pakistan Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.70302/jpsim.v6i4.2561</article-id>
      <article-id pub-id-type="publisher-id">jpsim.v6i4.2561</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Impact of Hyponatremia in Patients with Hepatitis C Induced Liver Cirrhosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Latif</surname>
            <given-names>Shahzad</given-names>
          </name>
          <email>shahzadlatif@hotmail.com</email>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Akram</surname>
            <given-names>Zaniab</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saleem</surname>
            <given-names>Hafiza Qaria Bushra</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Masood</surname>
            <given-names>Atika</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arshad</surname>
            <given-names>Atiqa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Anwar</surname>
            <given-names>Nishwa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Akhtar Saeed Medical College, Lahore</institution>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence: Shahzad Latif (shahzadlatif@hotmail.com)</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2025-11-21">
        <day>21</day>
        <month>11</month>
        <year>2025</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2025</year>
      </pub-date>
      <volume>6</volume>
      <issue>4</issue>
      <fpage>331</fpage>
      <lpage>335</lpage>
      <history>
        <date date-type="received" iso-8601-date="2025-05-18">
          <day>18</day>
          <month>05</month>
          <year>2025</year>
        </date>
        <date date-type="rev-recd" iso-8601-date="2025-08-22">
          <day>22</day>
          <month>08</month>
          <year>2025</year>
        </date>
        <date date-type="accepted" iso-8601-date="2025-10-10">
          <day>10</day>
          <month>10</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2025 The Author(s)</copyright-statement>
        <copyright-year>2025</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v6i4.2561" content-type="text/html"/>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v6i4.2561.pdf" content-type="application/pdf"/>
      <abstract>
        <sec>
          <title>Objective</title>
          <p>To assess the frequency of hyponatremia in admitted patients suffering from end stage liver disease because of hepatitis C infection in in Akhtar Saeed Trust Hospital, Lahore.</p>
        </sec>
        <sec>
          <title>Methodology</title>
          <p>It was an observational, cross sectional based study which was undertaken at Department of medicine, gastroenterology chapter, Akhtar Saeed Trust Hospital, Lahore during June 2023 to June 2024. The patients admitted in medical ward of Akhtar Saeed Trust Hospital Lahore diagnosed with end stage liver disease because of hepatitis C were monitored for their serum sodium levels. The respondents were divided into three different classes on basis of their serum sodium level in order to assess the impact of negative imbalance of sodium on the declining health of liver cirrhosis patients.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Hepatitis C, leading cause of liver cirrhosis in Pakistan and electrolytes imbalance mainly serum sodium level (Hyponatremia) is major causes of decompensation like Hepatic encephalopathy, upper gastrointestinal bleeding, Hepatorenal syndrome, Spontaneous bacterial peritonitis amongst patients having liver cirrhosis. It was found that hyponatremia level ≤130meq/L was found in 35.3% patients however, 41.3 % of the patient’s serum sodium level was between 130.50 to 134.50 meq/L, and 23.3 % patients had sodium levels &gt;134.50 meq/L. Serum sodium level has a strong association with liver cirrhosis patients in contest of Child Pugh score classification. It was found that 03 patients were in CPS class A, 13 within CPS class B and 37 patients within CPS class C having (serum sodium level equal or less than 130 meq/L). In group B (serum sodium level 130.50 to 134.50 meq/L) 07 patients were in CPS-A, 30 and 25 were in CPS-B and CPS-C, respectively. While in group C (serum sodium level above 134.50 meq/L), 11 patients were found in CPS-A, 15 were in CPS-B and 9 patients were in CPS-C (p value &lt; 0.0001).</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Hyponatremia is very crucial in prognosis of Liver cirrhosis patient as it increases MELD score and CTP score. It is inversely proportional to mortality, thus lower level of sodium leads to increase chances of mortality in patients with liver cirrhosis.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en" kwd-group-type="author-keywords">
        <title>Keywords</title>
        <kwd>Hyponatremia</kwd>
        <kwd>Liver cirrhosis</kwd>
        <kwd>Decompensated disease</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <!-- <body> omitted: no manuscript (.docx) on file -->
  <back>
    <notes notes-type="ethics-statement">
      <title>Ethics Statement</title>
      <p>Ethics committee: Ethics Committee, Akhtar Saeed Trust Hospital, Lahore, Pakistan. Approval number: 1457/ASTH, dated May 03, 2023.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease. Clin Gastroenterol Hepatol. 2020:18(12): 2650-66.</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Asrani SK,Dewarbhavi H, eaton J.Kamath PS. Burden of liver diseases in the world. J Hepatol 2019:70(1): 151-71.</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Bhatti ABH. Hepatocellular carcinoma in Pakistan: an update. InLiver Cancer in the Middle East. Cham: Springer International Publishing. 2021:387-96</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Abro IB,Bhatti JM, Siddiqui AA, Hepatocellular Carinima in Cirrhotic patients treated with different combination of Direct Acting Antiviral Agents Available in Pakistan: A Prospective Observational Study. Preprint. 2021; doi: <pub-id pub-id-type="doi">10.21203/rs.3.rs-444497/v1</pub-id>.</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Jamali YA, Noonari AG, Khuhro AB, Kalhoro S, Shah H, Gad AG. Prevalence of Hepatitis B and c in Pakistan from2001 to 2022: A systematic Review. J Health Rehab.2023;3(2):316-25.</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Al Kanaani Z, Muhammad S, Kouyoumjian SP, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Pakistan: Systematic review and meta-analyses. Royal Soc Open Sci. 2018:5(4): 180257.</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Alter MJ. Epidemiology of hepatitis C infection. World J Gastroenterol. 2007:13:2436.</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>Qureshi H, Bile KM, Jooma R , Alam SE, Afridi HU. Prevalence of hepatitis B &amp; C infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Medit Health J. 2010:16(1):15-23.</mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Trickey A, May MT, Davies C, Qureshi H, Hamid S, Mahmood H et al. Importance and contribution of community, social and healthcare risk factors for hepatitis C infection in Pakistan. Am J Trop Med Hyg. 2017:97(6):1920-1928.</mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Ghazal P. Rising trend of substance abuse in Pakistan: a study of sociodemographic profiles of patients admitted to rehabilitation canters. Public Health. 2019:167(1):34 - 7.</mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <mixed-citation>Shayan Sj, Nazari R, Kiwanuka F. Prevalence of HIV, and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis. Harm Reduction J. 2021:18(1):59.</mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <mixed-citation>Fattovich GI, Giustina GI, Degos FR, Tremolada FE, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterol. 1997;112(2):463-72.</mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <mixed-citation>Vezali E, Aghemo A, Colombo M. A review of the treatment of chronic hepatitis C virus infection in cirrhosis. Clin Therap. 2010;32(13):2117-38.</mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <mixed-citation>Leise MD, Findlay JY. Hyponatremia in the perioperative period: When and how to correct. Clin Liver Dis. 2017;9(5):111-4.</mixed-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <mixed-citation>Fortune BE, Garcia-Tsao G. Hypervolemic hyponatremia: Clinical significance and management. Clin Liver Dis. 2013;2(3):109-12.</mixed-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <mixed-citation>Nareddy SR, Aroor AR, Bhat A. Clinical Significance of Serum Sodium Levels in Liver Cirrhosis: A Crosssectional Observational Study. J Clin Diag Res. 2020;14(11):23.</mixed-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <mixed-citation>Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120(11):S1-21.</mixed-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <mixed-citation>Bernardi M, Laffi G, Salvagnini M, Azzena G, Bonato S, Marra F, et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver. 1993;13(3):156-62</mixed-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <mixed-citation>Brijesh B, Surbhi G. Hyponatremia in patients with chronic liver diseases, Journal of Cardiovasc Dis Res. 2023;14(1):3055-60.</mixed-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <mixed-citation>Sandeep R, Reddy S, Rchana B, Clinical Significance of Serum Sodium Levels in Liver Cirrhosis: A Cross sectional Observational Study. J Clin Diag Res. 2020 Nov; 14(11): 23-26.</mixed-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <mixed-citation>Dhawal V. Study the relation between serum sodium and the model for end-stage liver disease score in patients with liver cirrhosis, Int J Med Biomed Stud. 2021;5(3):123-5.</mixed-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <mixed-citation>Azam MU, Javed S, Memon MY, Aftab MA, Shafqat MN, Sadiq HZ, et al. Hyponatremia prevalence in decompensated chronic liver disease: insight from a tertiary care Hospital. Cureus. 2024;16(9): e68907.</mixed-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <mixed-citation>Younas A, Riaz J, Chughtai T, Saim M, Qazi S, Younus S, et al. Hyponatremia and Its Correlation with Hepatic Encephalopathy and Severity of Liver Disease. Cureus. 2021; 13(2):e-13175.</mixed-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <mixed-citation>Rajesh K, Anoop B. Significance of hyponatremia in decompensated chronic liver diseases. Sch J App Med Sci. 2016;4(2D):606-608.</mixed-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <mixed-citation>Jishnu S. study of serum sodium levels and its clinical significance in decompensated chronic liver disease patients admitted in a tertiary care centre of northeastern state, Tripura. Int J Adv Res. 2024; 12(09), 779-785.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
